This stock is only going one way!!
It's tripled in the last 12 months, so it is most definitely no fly buy!
It has now been de-risked, and will earn copious amounts of revenue with very little OpEx.
I have read an analyst report back in January this year, anticipating Rett FDA approval, and using conservative take up numbers of 20% only, at a patient cost of $125k USD annual. He finished up valuing the company at $35 AUD a share!!
The patient ones will continue to buy the dips, accumulate and soak up the selling from the uninformed and impatient.
This stock will change your life if you have the patience and the bottle to hold, just like it's going to change the poor girls that need it's magic potion!
GLTAH
All in my opinion only!
This stock is only going one way!! It's tripled in the last...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |